Other Events ·
On August 28, 2026, Lexaria (AU) Pty Ltd received an Australian R&D Tax Incentive Credit of AUD$3,666,611.98…
LEXXLexaria Bioscience Corp.
On August 28, 2026, Lexaria (AU) Pty Ltd received an Australian R&D Tax Incentive Credit of AUD$3,666,611.98 (approximately USD$2.6M) from the Australian Tax Office. This credit relates to research and development costs for the GLP-1-H24-4 clinical study and has been deposited into the subsidiary's bank account to fund further R&D in Australia. Lexaria Bioscience Corp. is a biotechnology company developing pharmaceutical drug products.